StonvexLoading…
StonvexStonvexStonvexCore line items from BZH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $2.37B | $2.33B | $2.21B | $2.32B |
Operating Income | $36.60M | $143.03M | $177.25M | $272.49M |
Net Income | $45.59M | $140.18M | $158.61M | $220.70M |
EPS (Diluted) | $1.52 | $4.53 | $5.16 | $7.17 |
Total Assets | $2.61B | $2.59B | $2.41B | $2.25B |
Total Liabilities | $1.36B | $1.36B | $1.31B | $1.31B |
Cash & Equivalents | $218.57M | $242.61M | $386.29M | $251.83M |
Free Cash Flow OCF − CapEx | $3.48M | $-159.90M | $157.72M | $66.03M |
Shares Outstanding | 29.76M | 31.05M | 31.35M | 30.88M |